KRAS and pancreatic neoplasm: p53 mutations are more commonly detected in mutant K-ras pancreatic tumors than that expressing wild-type p53, suggesting that K-ras mutations developed in early stages of pancreatic tumorigenesis, creates a genetic background favoring p53 mutations.